Johnson & Johnson (JNJ): 100 billion over 140 years

Johnson & Johnson is the oldest and most diversified company in the global pharmaceutical industry: prescription drugs and medical devices under one roof, a dividend that has grown for sixty-four consecutive years, and a top-tier credit rating. Over the past year, this typically stable stock has experienced a rare event—the market has sharply revalued it. We’ll examine what’s behind this, how the long-running talc controversy has played out, and which levels on the daily chart are currently important.